Resverlogix Corp trades with the ticker RVX on the TSX and is in the Biotechnology industry.
Overview
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada; and developing cardiovascular and pulmonary arterial hypertension indications. The company was founded in 2001 and is headquartered in Calgary, Canada.
Looking to invest in Resverlogix Corp? Our analysis brings in the key facts, competitor research and valuation metrics for you to make an informed decision.
Table of Contents
show
RVX.TO Stock Price and Key Stats
ETF Key Stats
Exchange: TSX
Market Cap : $16.33MM
PE Ratio:
Price: 23.9 (Updated: 3/12/2024 0:47:16)
Resverlogix Corp (RVX) vs Competitors in Biotechnology
Lets see how RVX.TO stacks up against others in the Biotechnology asset management industry. We have identified its main peers as:Aeterna Zentaris Inc, Aptose Biosciences Inc, BELLUS Health Inc, Fennec Pharmaceuticals Inc, IMV Inc
.Biotechnology Industry Comparisons
| Company | Market Cap ($MM) | P/E Ratio | EV/EBITDA | Dividend Yield |
|---|---|---|---|---|
| Aeterna Zentaris Inc (AEZS) | $12.674 | N/A | 1.709 | N/A% |
| Aptose Biosciences Inc (APS) | $33.927 | N/A | -0.231 | N/A% |
| BELLUS Health Inc (BLU) | $2,470.298 | N/A | -16.428 | 0.0% |
| Fennec Pharmaceuticals Inc (FRX) | $352.565 | N/A | -21.793 | N/A% |
| IMV Inc (IMV) | $13.117 | N/A | -0.843 | 0.0% |
EV/EBITDA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation, and Amortization – this ratio compares the value of a company, including debt, to the company’s cash earnings less non-cash expenses
Industry: companies that have a lot in common
Market Cap: Market Capitalization – the total value of all a corporation’s stock
N/A: Not Applicable or Not Available
P/E: Price-to-Earnings – this ratio relates a corporation’s share price to its earnings per share
Price: Stock Price – current value to buyers and sellers
Dividend Yield: Dividend or Distribution Yield
Comparisons within Biotechnology
- Resverlogix Corp (RVX) vs Aeterna Zentaris Inc (AEZS)
- RVX has higher EPS (-0.05 vs -6.47). AEZS and RVX both have P/E’s under 0.
- Resverlogix Corp (RVX) vs Aptose Biosciences Inc (APS)
- RVX has higher EPS (-0.05 vs -10.45). APS and RVX both have P/E’s under 0.
- Resverlogix Corp (RVX) vs BELLUS Health Inc (BLU)
- RVX has higher EPS (-0.05 vs -0.96). BLU provides dividends, while RVX does not. BLU and RVX both have P/E’s under 0.
- Resverlogix Corp (RVX) vs Fennec Pharmaceuticals Inc (FRX)
- RVX has higher EPS (-0.05 vs -1.01). FRX and RVX both have P/E’s under 0.
- Resverlogix Corp (RVX) vs IMV Inc (IMV)
- RVX has higher EPS (-0.05 vs -6.11). IMV provides dividends, while RVX does not. IMV and RVX both have P/E’s under 0.
Our Recommendation: Review
May not stand out on key metrics or lacks sufficient data for a strong recommendation.
How to Buy RVX stock on the TSX
You can buy on pretty much any online brokerage in Canada, since it trades on the TSX. If you are looking for some easy options take a look at these two:| Image | Product Title | Features | Price |
|---|---|---|---|
Editor's Choice  |
| Get $25 Signup Bonus | |
Reliable Pick  |
| Get $50 Free Stock Trades |
